+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

U.S. Retail Pharmacy Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Country

  • PDF Icon

    Report

  • 142 Pages
  • May 2025
  • Region: United States
  • Fairfield Market Research
  • ID: 6086601
The U.S. retail pharmacy market is witnessing a dynamic transformation, driven by an aging population, rising prevalence of chronic diseases, and technological innovations that are enhancing consumer access and service delivery. As the market evolves, retail pharmacies are becoming critical components of the nation’s healthcare infrastructure, providing not just medications but a wide array of healthcare services. According to updated industry insights, the U.S. retail pharmacy market is projected to grow from US$ 612.7 Bn in 2025 to US$ 867 Bn by 2032, expanding at a CAGR of 5.08% over the forecast period.

Market Insights

Retail pharmacies in the U.S. play a pivotal role in facilitating healthcare access, particularly amid shifting consumer preferences toward convenience and on-demand services. With 66% of the U.S. population reportedly using prescriptions in recent years, retail pharmacies have become integral for both medication dispensation and auxiliary services. These include vaccination administration, chronic disease management, diabetes education, and blood pressure monitoring, among others.

Consumer trust and ease of access are contributing to the market’s resilience. Retail chains such as CVS Health and Walgreens dominate the Analysis, supported by supermarket pharmacy departments and a growing ecosystem of online and mail-order pharmacies. This diversification is critical in addressing the broad and evolving healthcare needs of U.S. residents.

Drivers of Growth

Several key factors are fueling the upward momentum in the U.S. retail pharmacy market:

  • Rising Chronic Disease Burden: An increase in long-term illnesses such as diabetes, cardiovascular disease, and cancer is significantly boosting demand for prescription and over-the-counter (OTC) medications. Over 133 million Americans are estimated to live with at least one chronic condition.
  • Evolving Consumer Behavior: There is a clear shift in consumer preference toward digital healthcare solutions. The use of smartphones and digital platforms is making online and mail-order pharmacies increasingly attractive to the tech-savvy population.
  • Government Support and Healthcare Spending: U.S. healthcare programs and policies are aimed at increasing accessibility, especially for senior citizens under Medicare. Government-backed healthcare infrastructure enhancements are directly supporting the expansion of pharmacy services.
  • Technological Integration: Innovations such as AI-driven prescription management and telehealth services are enabling pharmacies to offer personalized care and operational efficiency, while reducing medication errors and improving adherence.

Business Opportunities

Opportunities abound for stakeholders in the U.S. retail pharmacy Analysis:

  • Growth of Mail-order and Online Pharmacies: The convenience of ordering medications online is accelerating the growth of ePharmacies. With nearly 92% of Americans owning a smartphone, the potential for digital pharmacy services is significant. Major players like Amazon and Walgreens are investing in AI-powered logistics to enable same-day and even 30-minute prescription deliveries.
  • Rise of Personalized Medicine: The increasing relevance of pharmacogenomics is opening doors for personalized treatment approaches. Retail pharmacies are beginning to collaborate with genomics firms to tailor medication therapies based on genetic profiles, especially for chronic illnesses and specialty drug management.
  • Specialty Drugs Expansion: Specialty drugs, including biologics and biosimilars, are gaining traction due to their effectiveness in treating complex diseases. Pharmacies are becoming integral hubs for administering and managing specialty medications, supported by clinical guidance and adherence support services.

Regional Analysis

The U.S. retail pharmacy market is geographically segmented into five zones - West, Midwest, Southwest, Southeast, and Northeast.
  • The Northeast U.S. remains a stronghold for legacy chains and high consumer density, contributing to higher per capita prescription volume.
  • The West U.S. is leading innovation in digital pharmacy solutions and telehealth integration, benefiting from tech-driven urban centers.
  • The Midwest and Southeast U.S. are seeing growth in regional pharmacy chains and community-based services, particularly in rural and suburban areas.
  • The Southwest U.S. offers expansion opportunities for new pharmacy chains and startups due to demographic growth and healthcare access challenges.

Key Players

The competitive Analysis in the U.S. retail pharmacy market features both well-established corporations and emerging players, each leveraging strategic expansions and partnerships to stay ahead:

  • CVS Health Corporation
  • Walgreens Boots Alliance, Inc.
  • Walmart Inc.
  • Rite Aid Corporation
  • CarelonRx
  • Costco Wholesale
  • Cigna
  • Humana
  • United Health Group
  • Publix
  • Albertsons Companies
  • BrightSpring Health Services
  • PANTHERx Rare Pharmacy
  • Ahold Delhaize
  • Centene
These players are focusing on digital transformation, personalized healthcare solutions, and integrated service offerings to retain and grow their customer base.

Recent Developments

Several major developments in 2024 have further shaped the trajectory of the market:

  • Walmart introduced prescription home delivery in six U.S. states, offering same-day and 30-minute options.
  • CVS Pharmacy launched the “Well Market” brand to diversify into nutritious foods and wellness-focused grocery items.
  • Walgreens expanded into gene and cell therapy management through a new specialty center in Pittsburgh.
  • WinnMed Pharmacy in Iowa opened a new retail location offering full-service pharmacy care, including vaccinations and medication adherence services.

U.S. Retail Pharmacy Market Segmentation

By Type of Pharmacy:

  • Chain Pharmacies
  • Independent Pharmacies
  • Hospital Pharmacies
  • Mail Order Pharmacies
  • Online Pharmacies

By Type of Prescription:

  • Prescription Drugs (Rx)
  • Over-the-Counter (OTC) Drugs

By Product Type:

  • Generic Drugs
  • Branded Drugs

By Application:

  • Cardiovascular
  • Central Nervous System
  • Gastrointestinal
  • Oncology
  • Others

By Customer Segment:

  • Pediatric
  • Adults
  • Geriatric

By Zone:

  • West U.S.
  • Midwest U.S.
  • Southwest U.S.
  • Southeast U.S.
  • Northeast U.S.

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. U.S. Retail Pharmacy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Zonal Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. U.S. Retail Pharmacy Market Outlook, 2019-2032
3.1. U.S. Retail Pharmacy Market Outlook, by Pharmacy Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Hospital Pharmacies
3.1.1.2. Independent Pharmacies
3.1.1.3. Chain Pharmacies
3.1.1.4. Online Pharmacies
3.1.1.5. Mail Order Pharmacies
3.2. U.S. Retail Pharmacy Market Outlook, by Prescription Type, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Over-the-Counter (OTC) Drugs
3.2.1.2. Prescription (Rx) Drugs
3.3. U.S. Retail Pharmacy Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Branded Drugs
3.3.1.2. Generic Drugs
3.4. U.S. Retail Pharmacy Market Outlook, by Zone, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Midwest U.S.
3.4.1.2. Southeast U.S.
3.4.1.3. Southwest U.S.
3.4.1.4. West U.S.
3.4.1.5. Northeast U.S.
4. Midwest U.S. Retail Pharmacy Market Outlook, 2019-2032
4.1. Midwest U.S. Retail Pharmacy Market Outlook, by Pharmacy Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Hospital Pharmacies
4.1.1.2. Independent Pharmacies
4.1.1.3. Chain Pharmacies
4.1.1.4. Online Pharmacies
4.1.1.5. Mail Order Pharmacies
4.2. Midwest U.S. Retail Pharmacy Market Outlook, by Prescription Type, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Over-the-Counter (OTC) Drugs
4.2.1.2. Prescription (Rx) Drugs
4.3. Midwest U.S. Retail Pharmacy Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Branded Drugs
4.3.1.2. Generic Drugs
5. Southeast U.S. Retail Pharmacy Market Outlook, 2019-2032
5.1. Southeast U.S. Retail Pharmacy Market Outlook, by Pharmacy Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Hospital Pharmacies
5.1.1.2. Independent Pharmacies
5.1.1.3. Chain Pharmacies
5.1.1.4. Online Pharmacies
5.1.1.5. Mail Order Pharmacies
5.2. Southeast U.S. Retail Pharmacy Market Outlook, by Prescription Type, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Over-the-Counter (OTC) Drugs
5.2.1.2. Prescription (Rx) Drugs
5.3. Southeast U.S. Retail Pharmacy Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Branded Drugs
5.3.1.2. Generic Drugs
6. Southwest U.S. Retail Pharmacy Market Outlook, 2019-2032
6.1. Southwest U.S. Retail Pharmacy Market Outlook, by Pharmacy Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Hospital Pharmacies
6.1.1.2. Independent Pharmacies
6.1.1.3. Chain Pharmacies
6.1.1.4. Online Pharmacies
6.1.1.5. Mail Order Pharmacies
6.2. Southwest U.S. Retail Pharmacy Market Outlook, by Prescription Type, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Over-the-Counter (OTC) Drugs
6.2.1.2. Prescription (Rx) Drugs
6.3. Southwest U.S. Retail Pharmacy Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Branded Drugs
6.3.1.2. Generic Drugs
7. West U.S. Retail Pharmacy Market Outlook, 2019-2032
7.1. West U.S. Retail Pharmacy Market Outlook, by Pharmacy Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Hospital Pharmacies
7.1.1.2. Independent Pharmacies
7.1.1.3. Chain Pharmacies
7.1.1.4. Online Pharmacies
7.1.1.5. Mail Order Pharmacies
7.2. West U.S. Retail Pharmacy Market Outlook, by Prescription Type, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Over-the-Counter (OTC) Drugs
7.2.1.2. Prescription (Rx) Drugs
7.3. West U.S. Retail Pharmacy Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Branded Drugs
7.3.1.2. Generic Drugs
8. Northeast U.S. Retail Pharmacy Market Outlook, 2019-2032
8.1. Northeast U.S. Retail Pharmacy Market Outlook, by Pharmacy Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Hospital Pharmacies
8.1.1.2. Independent Pharmacies
8.1.1.3. Chain Pharmacies
8.1.1.4. Online Pharmacies
8.1.1.5. Mail Order Pharmacies
8.2. Northeast U.S. Retail Pharmacy Market Outlook, by Prescription Type, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Over-the-Counter (OTC) Drugs
8.2.1.2. Prescription (Rx) Drugs
8.3. Northeast U.S. Retail Pharmacy Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Branded Drugs
8.3.1.2. Generic Drugs
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1.Walgreens Boots Alliance, Inc.
9.3.1.1. Company Overview
9.3.1.2. Service Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. CarelonRx
9.3.2.1. Company Overview
9.3.2.2. Service Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Costco Wholesale Corporation
9.3.3.1. Company Overview
9.3.3.2. Service Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. CVS Health
9.3.4.1. Company Overview
9.3.4.2. Service Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Walmart
9.3.5.1. Company Overview
9.3.5.2. Service Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. The Kroger Co.
9.3.6.1. Company Overview
9.3.6.2. Service Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Rite Aid Corp.
9.3.7.1. Company Overview
9.3.7.2. Service Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Publix Pharmacies
9.3.8.1. Company Overview
9.3.8.2. Service Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. PANTHERx Rare Pharmacy
9.3.9.1. Company Overview
9.3.9.2. Service Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
9.3.10. Albertsons Companies, Inc.
9.3.10.1. Company Overview
9.3.10.2. Service Portfolio
9.3.10.3. Financial Overview
9.3.10.4. Business Strategies and Development
9.3.11. Transform SR Brands, LLC
9.3.11.1. Company Overview
9.3.11.2. Service Portfolio
9.3.11.3. Financial Overview
9.3.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • CVS Health
  • Walgreens Boots Alliance
  • Walmart Inc.
  • Rite Aid
  • CarelonRx
  • Costco Wholesale
  • Cigna
  • Humana
  • United Health Group
  • Publix
  • Albertsons Companies
  • BrightSpring Health Services
  • PANTHERx Rare Pharmacy
  • Ahold Delhaize
  • Centene

Methodology

Loading
LOADING...